SP
BSX icon

Stonebrook Private’s Boston Scientific BSX Stock Holding History

Stonebrook Private’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,196
Closed -$209K – 228
2025
Q4 		$209K Buy
2,196
+55
+3% +$5.39K 0.04% 195
2025
Q3 		$209K Buy
2,141
+36
+2% +$3.73K 0.05% 193
2025
Q2 		$226K Buy
2,105
+31
+1% +$3.14K 0.05% 184
2025
Q1 		$209K Buy
+2,074
New +$209K 0.05% 181

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Stonebrook Private's BSX Position: Q1 2026 in Review

Stonebrook Private sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 2,196 shares — an estimated $209K sold.

Stonebrook Private first reported a position in BSX in Q1 2025 and held it in 4 quarters. The position peaked at $226K in Q2 2025. 1,678 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Stonebrook Private reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
  • Stonebrook Private sold 2,196 Boston Scientific shares in Q1 2026, an estimated $209K.
  • Stonebrook Private first reported a position in Boston Scientific in Q1 2025 and held it in 4 quarters.
  • Stonebrook Private's Boston Scientific position peaked at $226K in Q2 2025.
  • 1,678 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Stonebrook Private's 13F filing for Q1 2026, filed 11 May 2026.